Adam Weishaus
Analyst
UBS
Equibles does not estimate personal net worth.
About Adam Weishaus
Adam Weishaus is recorded as Analyst at UBS. Adam Weishaus has spoken on 1 earnings call across 1 company, most recently for Caris Life Sciences, Inc. on November 4, 2026. The companies whose calls Adam Weishaus spoke on are classified in the Healthcare sector.
Adam Weishaus on recent calls
“You mentioned that a share is going to move to the higher CLFS rate in January. I'm just curious, how are you thinking about that magnitude and timing of the benefit to realized AFP in 2027, particularly as you've mentioned, commercial contracts are generally priced as a percentage of that CLFS rate?”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current